Anna Maria Orengo Selected Research

Anna Maria Orengo Research Topics

Disease

22	Neoplasms (Cancer) 01/2021 - 07/2003
4	Neuroblastoma 12/2020 - 01/2005
4	Ovarian Epithelial Carcinoma 09/2013 - 12/2007
3	Hyperglycemia 10/2020 - 01/2020
3	Carcinoma (Carcinomatosis) 01/2016 - 12/2007
2	Breast Neoplasms (Breast Cancer) 01/2016 - 11/2013
2	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 09/2015 - 01/2015
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 06/2015 - 08/2009
2	Adenocarcinoma 02/2006 - 02/2004
1	Hodgkin Disease (Hodgkin's Disease) 04/2022
1	Type 2 Diabetes Mellitus (MODY) 01/2021
1	Lung Neoplasms (Lung Cancer) 12/2020
1	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 07/2020
1	Diabetes Mellitus 01/2020
1	Starvation 01/2016
1	Disease Progression 09/2015
1	Necrosis 11/2013
1	Triple Negative Breast Neoplasms 11/2013
1	Ovarian Neoplasms (Ovarian Cancer) 09/2013
1	Ascites 06/2013
1	HIV Infections (HIV Infection) 09/2012
1	Endometrial Neoplasms (Endometrial Cancer) 09/2011
1	Glioma (Gliomas) 10/2007
1	Glioblastoma (Glioblastoma Multiforme) 10/2007
1	Carcinogenesis 07/2007
1	Neoplasm Micrometastasis 02/2006
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 07/2003

Drug/Important Bio-Agent (IBA)

10	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 01/2013
7	Metformin (Glucophage)FDA LinkGeneric 01/2021 - 01/2013
5	interleukin-21 (interleukin 21)IBA 01/2015 - 02/2004
4	Pharmaceutical PreparationsIBA 01/2021 - 05/2012
4	Interleukin-12 (IL 12)IBA 10/2007 - 07/2003
3	Proteins (Proteins, Gene)FDA Link 09/2015 - 10/2007
3	Messenger RNA (mRNA)IBA 01/2015 - 08/2009
3	VaccinesIBA 05/2014 - 02/2006
3	CytokinesIBA 05/2014 - 10/2007
3	Interleukin-15 (Interleukin 15)IBA 09/2012 - 07/2003
3	InterleukinsIBA 09/2011 - 10/2007
2	Biological ProductsIBA 12/2020 - 09/2011
2	Streptozocin (Streptozotocin)FDA Link 05/2020 - 01/2020
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2020 - 01/2016
2	HexokinaseIBA 01/2016 - 11/2013
2	Interleukin-18 (Interleukin 18)IBA 09/2013 - 09/2011
2	Biomarkers (Surrogate Marker)IBA 06/2013 - 09/2011
2	Activated-Leukocyte Cell Adhesion Molecule (Neurolin)IBA 06/2013 - 12/2007
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 08/2009 - 02/2004
2	AntigensIBA 10/2007 - 07/2007
2	Immunoglobulin G (IgG)IBA 10/2007 - 07/2003
1	AMP-Activated Protein KinasesIBA 01/2021
1	BiguanidesIBA 01/2021
1	Ribose (D-Ribose)IBA 12/2020
1	Glucosephosphate Dehydrogenase (Glucose 6 Phosphate Dehydrogenase)IBA 12/2020
1	EnzymesIBA 12/2020
1	Liposomes (Liposome)IBA 12/2020
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 07/2020
1	Dihydrotachysterol (AT 10)IBA 05/2020
1	AntioxidantsIBA 01/2020
1	NADP (NADPH)IBA 01/2020
1	Adenosine Triphosphate (ATP)IBA 01/2016
1	Cytostatic AgentsIBA 09/2015
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 06/2015
1	Cisplatin (Platino)FDA LinkGeneric 06/2015
1	AfatinibIBA 06/2015
1	Epithelial Cell Adhesion MoleculeIBA 06/2015
1	ErbB Receptors (EGF Receptor)IBA 06/2015
1	MicroRNAs (MicroRNA)IBA 01/2015
1	AntibodiesIBA 05/2014
1	Protein Isoforms (Isoforms)IBA 06/2013
1	ArginaseIBA 08/2009
1	Interleukin-8 (Interleukin 8)IBA 08/2009
1	Metalloproteases (Metalloproteinases)IBA 12/2007
1	Complement System Proteins (Complement)IBA 10/2007
1	Interleukin-2 (IL2)IBA 10/2007
1	Tumor Viral Antigens (Large T Antigen)IBA 07/2007
1	Combined VaccinesIBA 07/2007
1	Therapeutic UsesIBA 01/2005
1	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 02/2004
1	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 02/2004
1	CXC ChemokinesIBA 02/2004

Therapy/Procedure

6	Immunotherapy 05/2014 - 02/2006
3	Therapeutics 01/2016 - 01/2005
1	Drug Therapy (Chemotherapy) 04/2022
1	Combination Drug Therapy (Combination Chemotherapy) 06/2015